Breast Cancer

Papers
(The median citation count of Breast Cancer is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis109
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status84
Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis68
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives60
A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer46
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition42
Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer37
Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions34
Axillary surgery for breast cancer: past, present, and future31
High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE 31
Annual report of the Japanese Breast Cancer Registry for 201729
The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast27
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer26
Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer26
The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients26
Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer25
Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer25
Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis24
Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors24
Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project24
Circular RNAs serve as miRNA sponges in breast cancer24
Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)23
Immune-related biomarkers in triple-negative breast cancer23
Effects of yoga on improving quality of life in patients with breast cancer: a meta-analysis of randomized controlled trials22
Annual report of the Japanese Breast Cancer Society registry for 201621
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells21
Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis20
Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells20
Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast20
Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis20
Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells via miR-21-5p/ZNF367 pathway20
Resistance training in breast cancer patients undergoing primary treatment: a systematic review and meta-regression of exercise dosage20
Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration18
miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC118
Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line18
Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis18
CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients17
Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan17
Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells16
Overall assessment system of combined mammography and ultrasound for breast cancer screening in Japan16
PI3K/AKT and MAPK1 molecular changes preceding matrix metallopeptidases overexpression during tamoxifen-resistance development are correlated to poor prognosis in breast cancer patients16
Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review16
A systematic review of behaviour change techniques used in interventions to increase physical activity among breast cancer survivors16
The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy16
Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes16
Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)15
Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms15
Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic reso14
Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis14
Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency14
The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images14
Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews13
Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literature12
Effects of a personal trainer-led exercise intervention on physical activity, physical function, and quality of life of breast cancer survivors12
Impact of artificial intelligence in breast cancer screening with mammography12
Decreased ER dependency after acquired resistance to CDK4/6 inhibitors12
Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance12
Association between dietary phytochemical index and breast cancer: a case–control study12
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer12
Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient’s perspective11
Nipple-sparing mastectomy for breast cancer close to the nipple: a single institution’s 11-year experience11
Taste alterations in patients with breast cancer following chemotherapy: a cohort study11
XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis11
Mapping the cancer-specific FACT-B onto the generic SF-6Dv211
Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +11
Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases10
Fertility under uncertainty: exploring differences in fertility-related concerns and psychosocial aspects between breast cancer survivors and non-cancer infertile women10
Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan10
Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand10
miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers10
Non-invasive quantitative measures of qualitative grading effectiveness as the indices of acute radiation dermatitis in breast cancer patients10
Interleukin-34 contributes to poor prognosis in triple-negative breast cancer10
The transverse musculocutaneous gracilis flap for autologous breast reconstruction: focus on donor site morbidity10
Novel module and hub genes of distinctive breast cancer associated fibroblasts identified by weighted gene co‐expression network analysis10
Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan9
Sexuality in breast cancer survivors: sexual experiences, emotions, and cognitions in a group of women under hormonal therapy9
Integrative review of breast cancer survivors’ transition experience and transitional care: dialog with transition theory perspectives9
Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes9
The safety of performing breast reconstruction during the COVID-19 pandemic9
Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report9
SNORA71B promotes breast cancer cells across blood–brain barrier by inducing epithelial-mesenchymal transition9
Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT19
Development and biological assessment of MMAE-trastuzumab antibody–drug conjugates (ADCs)9
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospect9
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population9
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced brea9
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer 9
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 20188
LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-2998
Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review8
Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer8
Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study8
Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan8
Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases8
Changes in neutrophil to lymphocyte ratio (NLR) during neoadjuvant treatment correlated with patients’ survival8
Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer8
The effect of preoperative depression and anxiety on heart rate variability in women with breast cancer8
Breast cancer populations may have an increased prevalence of thyroglobulin antibody and thyroid peroxidase antibody: a systematic review and meta-analysis8
Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 − negative subtype8
Optimal duration of endocrine therapy with extended aromatase inhibitors for postmenopausal patients with hormone receptor-positive breast cancer: a meta-analysis8
The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis8
The associations of healthy lifestyle index with breast cancer incidence and mortality in a population-based study7
A novel immune-related prognostic index for predicting breast cancer overall survival7
Perceived physical fatigability improves after an exercise intervention among breast cancer survivors: a randomized clinical trial7
PAM50- and immunohistochemistry-based subtypes of breast cancer and their relationship with breast cancer mortality in a population-based study7
Diagnostic performance of dedicated breast positron emission tomography7
Detection of breast cancer precursor lesions by autofluorescence ductoscopy7
Differential expression of the BCAT isoforms between breast cancer subtypes7
Prognostic model based on six PD-1 expression and immune infiltration-associated genes predicts survival in breast cancer7
Subcellular localization of EZH2 phosphorylated at T367 stratifies metaplastic breast carcinoma subtypes7
Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer7
Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer7
Kounis syndrome after patent blue dye injection for sentinel lymph node biopsy7
Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population7
KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer7
Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema7
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry7
Sedentary behavior and risk of breast cancer: a dose–response meta-analysis from prospective studies6
Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of Japan6
Nationwide mammographic screening and breast cancer mortality in Taiwan: an interrupted time-series analysis6
Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer6
PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing6
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)6
Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer6
The impact of cognitive impairment on survival and medication adherence among older women with breast cancer6
Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study6
Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis6
Immediate one-stage implant-based breast reconstruction without the use of acellular dermal matrix in Japanese breast cancer patients6
LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF66
Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population6
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis6
Understanding breast cancer heterogeneity through non-genetic heterogeneity6
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results6
Usefulness of new shear wave elastography in early predicting the efficacy of neoadjuvant chemotherapy for patients with breast cancer: where and when to measure is optimal?6
BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion6
Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance6
Current status of breast cancer screening in high-risk women in Japan6
Body size, silhouette trajectory and the risk of breast cancer in a Moroccan case–control study6
3-Dimensional objective aesthetic evaluation to replace panel assessment after breast-conserving treatment6
Comparative evaluation of nuclear and histological grades as prognostic factors for invasive breast cancer6
Relationship between MRI findings and invasive breast cancer with podoplanin-positive cancer-associated fibroblasts5
Role of dietary fat on obesity-related postmenopausal breast cancer: insights from mouse models and methodological considerations5
Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction5
In vitro anti-breast cancer studies of LED red light therapy through autophagy5
Prognostic factors for breast cancer patients with T1–2 tumors and 1–3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients5
Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib plus endocrine ther5
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer5
Assessment of integrative non-pharmacological interventions and quality of life in breast cancer patients using real-world data5
Can breast MRI and adjunctive Doppler ultrasound improve the accuracy of predicting pathological complete response after neoadjuvant chemotherapy?5
A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer5
Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant5
Breast cancer screening using digital breast tomosynthesis compared to digital mammography alone for Japanese women5
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up5
TP53 signature diagnostic system using multiplex reverse transcription–polymerase chain reaction system enables prediction of prognosis of breast cancer patients5
Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer Society5
Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan5
Correlation between modified Magee equation-2 and Oncotype-Dx recurrence scores using both traditional and TAILORx cutoffs and the clinical application of the Magee Decision Algorithm: a single instit5
Current status of MRI-guided vacuum-assisted breast biopsy in Japan5
The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer5
Conservative axillary surgery is emerging in the surgical management of breast cancer5
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin5
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL): a challenging cytological diagnosis with hybrid PET/MRI staging and follow-up5
Evaluation of the ability of the Clinical Treatment Score at 5 years (CTS5) compared to other risk stratification methods to predict the response to an extended endocrine therapy in breast cancer pati5
HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC5
Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)5
Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients5
Analysis of RPL37A, MTSS1, and HTRA1 expression as potential markers for pathologic complete response and survival5
Comparing the extent of breast cancer tumors through contrast-enhanced ultrasound vs B-mode, opposed with pathology: evergreen study5
Use and impact of breast cancer survivorship care plans: a systematic review4
Skin grafting utilizing a skin of lateral thoracic area for chest wall reconstruction in patient who underwent mastectomy for locally advanced breast cancer4
Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy4
EZH2 knockdown in tamoxifen-resistant MCF-7 cells unravels novel targets for regaining sensitivity towards tamoxifen4
Adenosquamous carcinoma of the breast: a population-based study4
Average lifespan shortened due to breast cancer in Australia, 1990–20154
The effects of home-based exercise therapy for breast cancer-related fatigue induced by radical radiotherapy4
Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratio4
Features from MRI texture analysis associated with survival outcomes in triple-negative breast cancer patients4
The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs4
Comparison of thoracic and abdominal deep inspiration breath holds in whole-breast irradiation for patients with left-sided breast cancer4
Phytochemical-conjugated bio-safe gold nanoparticles in breast cancer: a comprehensive update4
A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan4
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow4
Effect of radiotherapy after breast-conserving surgery in elderly patients with early breast cancer according to the AJCC 8th Edition Breast Cancer Staging System in Japan4
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD34
Effect of patient decision aids on decisional conflict and regret associated with breast cancer surgery: a randomized controlled trial4
High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer4
The feasibility of pelvic floor training to treat urinary incontinence in women with breast cancer: a telehealth intervention trial4
The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women4
Genitourinary symptoms in women with breast cancer: what do oncology health professionals think and do about them?4
Genetic medicine is accelerating in Japan4
Clinical outcomes and patient satisfaction with the use of biological and synthetic meshes in one-stage implant-based breast reconstruction4
Interactions between exposure to polycyclic aromatic hydrocarbons and xenobiotic metabolism genes, and risk of breast cancer4
Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer4
Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients4
Breast cancer patient-reported outcome of factors influencing cosmetic satisfaction after breast-conserving therapy4
Targeting of antitumor ımmune responses with live-attenuated Leishmania strains in breast cancer model4
Systematic review of synchronous contralateral axillary metastases in breast cancer: really M1 disease?3
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database3
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor3
The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution3
Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society3
Pure ground glass opacity (GGO) on chest CT: a rare presentation of lung metastasis of Malignant Phyllodes Tumor3
Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum3
Gene expression profile of normal breast tissue and body mass index3
Investigation of the significance of population-based breast cancer screening among women aged under 40 years3
Internal mammary lymph node metastasis in breast cancer patients based on anatomical imaging and functional imaging3
Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study3
Optimizing breast cancer surgery during the COVID-19 pandemic3
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 mo3
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry3
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan3
Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients3
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud3
Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial3
Gene-to-gene interactions and the association of TP53, XRCC1, TNFα, HMMR, MDM2 and PALB2 with breast cancer in Kyrgyz females3
Predictive and prognostic significance of BRCAness in HER2-negative breast cancer3
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches3
Variant in BCAR4 gene correlated with the breast cancer susceptibility and mRNA expression of lncRNA BCAR4 in Chinese Han population3
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM13
Dietary intake of branched-chain amino acids in relation to the risk of breast cancer3
Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies3
miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast3
New variant of breast-invasive lobular carcinoma with solid and encapsulated papillary carcinoma growth pattern3
A history of severe nausea and vomiting during pregnancy predicts a higher incidence of postoperative nausea and vomiting after breast cancer surgery without breast reconstruction3
Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI3
FE65 in breast cancer and its clinicopathological significance3
Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up3
Identifying women with increased risk of breast cancer and implementing risk-reducing strategies and supplemental imaging2
Beneficial effects of transdermal administration of tamoxifen on capsular contracture after breast implantation in murine models2
Comparison of short-term outcomes between pedicled- and free-flap autologous breast reconstruction: a nationwide inpatient database study in Japan2
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women2
Biology of primary breast cancer in older women beyond routine biomarkers2
Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases2
Physician’s knowledge, attitudes and practice pattern for breast cancer diagnosed during pregnancy: a survey among breast care specialists in Japan2
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer2
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome2
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence2
Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer2
An investigation into socio-demographic-, health-, and cancer-related factors associated with cortisol and C-reactive protein levels in breast cancer survivors: a longitudinal study2
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study2
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study2
The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer2
Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cyt2
Multi-time scale transcriptomic analysis on the dynamic process of tamoxifen resistance development in breast cancer cell lines2
Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo‐adjuvant chemotherapy2
Neurospora crassa is a potential source of anti-cancer agents against breast cancer2
A novel ADC targeting cell surface fibromodulin in a mouse model of triple-negative breast cancer2
Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer2
Behavior of Japanese women after being informed about the benefits and disadvantages of breast cancer screening: a questionnaire survey2
Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observ2
0.046518087387085